Gires–Tournois Immunoassay Platform for Label‐Free Bright‐Field Imaging and Facile Quantification of Bioparticles
Иммуноаналитическая платформа Гира–Турноа для бесконтрастной визуализации в светлом поле и простой количественной оценки биочастиц
2022-03-26
SCID: 54.1/3e8vqw2k
Discuss with AI
Gires–Tournois immunoassay platformbioparticle quantificationchromaticity analysislabel-free bright-field imagingmultiscale sensing
Figures from the paper
Abstract (AI)
Bright-field imaging of nanoscale bioparticles is a challenging task for optical microscopy because the light-matter interactions of bioparticles are weak on conventional surfaces due to their low refractive index and small size. Alternatively, advanced imaging techniques, including near-field microscopy and phase microscopy, have enabled visualization and quantification of the bioparticles, but they require assistance of sophisticated/customized systems and post-processing with complex established algorithms. Here, a simple and fast immunoassay device, Gires-Tournois immunoassay platform (GTIP) is presented, which provides unique color dynamics in response to optical environment changes and thus enables the label-free bright-field imaging and facile quantification of bioparticles using conventional optical microscopy. Bioparticles on GTIP slow down the velocity of reflected light, leading to vivid color change according to the local particle density and maximizing chromatic contrast for high spatial distinguishability. The particle distribution and density on the surface of the resonator are readily analyzed through 2D raster-scanning-based chromaticity analysis. GTIP offers multiscale sensing capability for target analytes that possess different refractive indices and sizes.
Key Findings
1
Bioparticle binding changes the reflected-light velocity and produces vivid, density-dependent color shifts that enhance chromatic contrast and spatial distinguishability.
2
GTIP provides multiscale sensing for analytes with different refractive indices and sizes without requiring sophisticated imaging systems or complex post-processing.
3
The Gires–Tournois immunoassay platform enables label-free bright-field imaging of nanoscale bioparticles using conventional optical microscopy.
4
Two-dimensional raster-scanning chromaticity analysis enables straightforward determination of particle distribution and surface density.
Research Object
Gires–Tournois immunoassay platform with surface-bound bioparticles
Research Subject
Label-free bright-field imaging and chromaticity-based quantification of bioparticle distribution and density across analytes with different refractive indices and sizes
Publication Details
Publication Date
2022-03-26
Journal
Publisher
ISSN
Cited by
30
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest